双语例句
- There is no apparent difference in early outcomes of patients treated with eptifibatide compared with patients treated with abciximab.
接受替非罗班治疗的患者的早期结果和接受阿昔单抗治疗的患者相比，不存在显著性差异。
权威例句
Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized tr...Abciximab improves both epicardial flow and myocardial reperfusion in ST-elevation myocardial infarction. Observations from the TIMI...Combination Therapy With Abciximab Reduces Angiographically Evident Thrombus in Acute Myocardial Infarction A TIMI 14 SubstudyAbciximab facilitates the rate and extent of thrombolysis: results of the thrombolysis in myocardial infarction (TIMI) 14 trial. The...Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction.Abciximab in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention After Clopidogrel Pretreatment: Th...Tirofiban and sirolimus-eluting stent vs abciximab and bare-metal stent for acute myocardial infarction: a randomized trial.Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE ...Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels. c7E3 Fab Antiplatelet Thera...Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with per...
